Advertisement
Screener

Perrigo Company plc (PRGO) Increase (Decrease) in Other Operating Assets and Liabilities, Net

Perrigo Company plc Increase (Decrease) in Other Operating Assets and Liabilities, Net

Perrigo Company plc (PRGO) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-02-26

  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-27 was $0.00.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-06-28 was $2.50M, a 91.86% decline year-over-year.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-03-29 was -$2.50M.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $0.00.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$1.50M.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$25.90M.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$35.20M, a 848.94% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$2.50M
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2025-09-27$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$2.50M
derived: sum of 2 quarters · filed 2025-11-05
$0.00
10-Q · filed 2025-11-05
$19.60M
derived: sum of 4 quarters · filed 2026-02-26
2025-06-28$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$0.00
10-Q · filed 2025-08-06
$19.60M
derived: sum of 3 quarters · filed 2026-02-26
-$14.80M
derived: sum of 4 quarters · filed 2026-02-26
2025-03-29-$2.50M
10-Q · filed 2025-05-07
$17.10M
derived: sum of 2 quarters · filed 2026-02-26
-$17.30M
derived: sum of 3 quarters · filed 2026-02-26
$13.40M
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$19.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$14.80M
derived: sum of 2 quarters · filed 2026-02-26
$15.90M
derived: sum of 3 quarters · filed 2026-02-26
-$1.50M
10-K · filed 2026-02-26
2024-09-28-$34.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$3.70M
derived: sum of 2 quarters · filed 2025-11-05
-$21.10M
10-Q · filed 2025-11-05
-$36.00M
10-Q · filed 2024-11-06
-$28.20M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-29$30.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$13.30M
10-Q · filed 2025-08-06
$6.20M
derived: sum of 3 quarters · filed 2026-02-26
$3.20M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-30-$17.40M
10-Q · filed 2025-05-07
-$24.50M
derived: sum of 2 quarters · filed 2026-02-26
-$27.50M
derived: sum of 3 quarters · filed 2026-02-26
-$33.10M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$7.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$10.10M
derived: sum of 2 quarters · filed 2026-02-26
-$15.70M
derived: sum of 3 quarters · filed 2026-02-26
-$25.90M
10-K · filed 2026-02-26
-$33.50M
10-K · filed 2024-02-27
2023-09-30-$3.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$8.60M
derived: sum of 2 quarters · filed 2024-11-06
-$18.80M
10-Q · filed 2024-11-06
-$31.60M
derived: sum of 4 quarters · filed 2025-02-28
2023-07-01-$5.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
-$15.80M
10-Q · filed 2024-08-02
-$28.60M
derived: sum of 3 quarters · filed 2025-02-28
-$42.30M
derived: sum of 4 quarters · filed 2025-02-28
2023-04-01-$10.20M
10-Q · filed 2024-05-07
-$23.00M
derived: sum of 2 quarters · filed 2025-02-28
-$36.70M
derived: sum of 3 quarters · filed 2025-02-28
-$45.30M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$12.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$26.50M
derived: sum of 2 quarters · filed 2025-02-28
-$35.10M
derived: sum of 3 quarters · filed 2025-02-28
-$35.20M
10-K · filed 2025-02-28
2022-10-01-$13.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$22.30M
derived: sum of 2 quarters · filed 2023-11-07
-$22.40M
10-Q · filed 2023-11-07
-$54.50M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-02-$8.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$8.70M
10-Q · filed 2023-08-08
-$21.40M
10-Q · filed 2022-08-09
-$40.80M
derived: sum of 3 quarters · filed 2024-02-27
$27.20M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-02-$100.00K
10-Q · filed 2023-05-09
-$8.30M
10-Q · filed 2022-05-11
-$32.20M
derived: sum of 2 quarters · filed 2024-02-27
$35.80M
derived: sum of 3 quarters · filed 2024-02-27
$27.10M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31-$32.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$35.90M
derived: sum of 2 quarters · filed 2024-02-27
$27.20M
derived: sum of 3 quarters · filed 2024-02-27
$4.70M
10-K · filed 2024-02-27
2021-10-02$68.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$59.30M
derived: sum of 2 quarters · filed 2022-11-08
$36.80M
10-Q · filed 2022-11-08
$40.60M
derived: sum of 4 quarters · filed 2023-02-28
2021-07-03-$8.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$31.20M
10-Q · filed 2022-08-09
-$27.40M
derived: sum of 3 quarters · filed 2023-02-28
-$39.10M
derived: sum of 4 quarters · filed 2023-02-28
2021-04-03-$22.50M
10-Q · filed 2022-05-11
-$18.70M
derived: sum of 2 quarters · filed 2023-02-28
-$30.40M
derived: sum of 3 quarters · filed 2023-02-28
-$39.10M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$3.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$7.90M
derived: sum of 2 quarters · filed 2023-02-28
-$16.60M
derived: sum of 3 quarters · filed 2023-02-28
-$10.10M
10-K · filed 2023-02-28
$2.20M
10-K · filed 2021-03-01
2020-09-26-$11.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$20.40M
derived: sum of 2 quarters · filed 2021-11-12
-$13.90M
10-Q · filed 2021-11-12
-$20.50M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-27-$8.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$2.20M
10-Q · filed 2021-08-11
-$8.80M
derived: sum of 3 quarters · filed 2022-03-01
-$11.90M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-28$6.50M
10-Q · filed 2021-05-12
-$100.00K
derived: sum of 2 quarters · filed 2022-03-01
-$3.20M
derived: sum of 3 quarters · filed 2022-03-01
-$7.80M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$6.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$9.70M
derived: sum of 2 quarters · filed 2022-03-01
-$14.30M
derived: sum of 3 quarters · filed 2022-03-01
-$27.20M
10-K · filed 2022-03-01
2019-09-28-$3.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$7.70M
derived: sum of 2 quarters · filed 2020-11-05
-$20.60M
10-Q · filed 2020-11-05
-$15.90M
10-Q · filed 2019-11-06
-$16.20M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-29-$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$17.50M
10-Q · filed 2020-08-05
-$19.90M
10-Q · filed 2019-08-08
-$13.10M
derived: sum of 3 quarters · filed 2021-03-01
-$14.60M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-30-$12.90M
10-Q · filed 2020-05-05
-$9.20M
10-Q · filed 2019-05-09
-$8.50M
derived: sum of 2 quarters · filed 2021-03-01
-$10.00M
derived: sum of 3 quarters · filed 2021-03-01
-$26.30M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$2.90M
derived: sum of 2 quarters · filed 2021-03-01
-$13.40M
derived: sum of 3 quarters · filed 2021-03-01
$8.80M
10-K · filed 2021-03-01
2018-09-29-$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$17.80M
derived: sum of 2 quarters · filed 2019-11-06
$4.40M
10-Q · filed 2019-11-06
$12.70M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$16.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$5.90M
10-Q · filed 2019-08-08
$14.20M
derived: sum of 3 quarters · filed 2020-02-27
-$2.60M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$22.20M
10-Q · filed 2019-05-09
$30.50M
derived: sum of 2 quarters · filed 2020-02-27
$13.70M
derived: sum of 3 quarters · filed 2020-02-27
$100.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$8.50M
derived: sum of 2 quarters · filed 2020-02-27
-$22.10M
derived: sum of 3 quarters · filed 2020-02-27
$4.80M
10-K · filed 2020-02-27
2017-09-30-$16.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$30.40M
derived: sum of 2 quarters · filed 2018-11-08
-$3.50M
10-Q · filed 2018-11-08
-$600.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-07-01-$13.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$13.30M
10-Q · filed 2018-08-09
$16.20M
derived: sum of 3 quarters · filed 2019-02-27
-$3.80M
derived: sum of 4 quarters · filed 2019-02-27
2017-04-01$26.90M
10-Q · filed 2018-05-08
$29.80M
derived: sum of 2 quarters · filed 2019-02-27
$9.80M
derived: sum of 3 quarters · filed 2019-02-27
$38.40M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$17.10M
derived: sum of 2 quarters · filed 2019-02-27
$11.50M
derived: sum of 3 quarters · filed 2019-02-27
$12.30M
10-K · filed 2019-02-27
2016-10-01-$20.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$8.60M
derived: sum of 2 quarters · filed 2017-11-09
$9.40M
10-Q · filed 2017-11-09
$31.00M
10-Q · filed 2016-11-10
$300.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-07-02$28.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$29.40M
10-Q · filed 2017-08-10
$45.40M
10-Q · filed 2016-08-10
$20.30M
derived: sum of 3 quarters · filed 2018-03-01
$26.50M
derived: sum of 4 quarters · filed 2018-03-01
2016-04-02$800.00K
10-Q · filed 2017-05-30
$25.30M
10-Q · filed 2016-05-16
-$8.30M
derived: sum of 2 quarters · filed 2018-03-01
-$2.10M
derived: sum of 3 quarters · filed 2018-03-01
-$24.60M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$9.10M
derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01
-$2.90M
10-K · filed 2018-03-01
$4.80M
10-KT · filed 2016-02-25
-$25.40M
derived: sum of 3 quarters · filed 2018-03-01
-$21.60M
derived: sum of 4 quarters · filed 2018-03-01
2015-09-26$6.20M
10-Q · filed 2015-11-02
-$16.30M
derived: sum of 2 quarters · filed 2017-05-22
-$13.70M
10-Q/A · filed 2017-05-23
$6.70M
10-Q · filed 2016-11-10
-$8.10M
derived: sum of 4 quarters · filed 2017-05-22
2015-06-27-$22.50M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22
-$18.70M
10-Q/A · filed 2017-05-22
$600.00K
10-Q · filed 2016-08-10
-$14.30M
derived: sum of 3 quarters · filed 2017-05-22
-$600.00K
10-K · filed 2018-03-01
$16.80M
10-K · filed 2015-08-13
2015-03-28$3.80M
10-Q/A · filed 2017-05-22
$2.00M
10-Q · filed 2016-05-16
$8.20M
derived: sum of 2 quarters · filed 2017-05-22
$18.40M
10-Q · filed 2015-04-29
-$15.10M
derived: sum of 4 quarters · filed 2017-05-22
2014-12-27$4.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05
$16.40M
10-Q · filed 2015-02-05
-$18.90M
derived: sum of 3 quarters · filed 2017-05-22
-$31.30M
derived: sum of 4 quarters · filed 2017-05-22
2014-09-27$12.00M
10-Q · filed 2015-11-02
-$23.30M
derived: sum of 2 quarters · filed 2017-05-22
-$35.70M
derived: sum of 3 quarters · filed 2017-05-22
-$17.50M
derived: sum of 4 quarters · filed 2017-05-22
2014-06-28-$35.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22
-$47.70M
derived: sum of 2 quarters · filed 2017-05-22
-$29.50M
derived: sum of 3 quarters · filed 2017-05-22
-$31.90M
10-K · filed 2017-05-22
-$33.90M
10-K · filed 2014-08-14
2014-03-29-$12.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29
$5.80M
derived: sum of 2 quarters · filed 2015-04-29
$3.40M
10-Q · filed 2015-04-29
$6.70M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-28$18.20M
derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05
$15.80M
10-Q · filed 2015-02-05
$19.10M
derived: sum of 3 quarters · filed 2016-02-25
$4.40M
derived: sum of 4 quarters · filed 2016-02-25
2013-09-28-$2.40M
8-K · filed 2014-11-20
$900.00K
derived: sum of 2 quarters · filed 2016-02-25
-$13.80M
derived: sum of 3 quarters · filed 2016-02-25
2013-06-29$3.30M
derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25
-$11.40M
derived: sum of 2 quarters · filed 2016-02-25
-$15.30M
10-KT · filed 2016-02-25
2013-03-30-$14.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07
-$18.60M
10-Q · filed 2014-05-07
2012-12-29-$3.90M
10-Q · filed 2014-02-06
2012-06-30$5.70M
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38